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The widely used biocide triclosan selectively targets FabI, the NADH-dependent
trans-2-enoyl-acyl carrier protein (ACP) reductase, which is also an important target
for the development of narrow spectrum antibiotics. The analysis of triclosan resistant
Staphylococcus aureus isolates had previously shown that in about half of the strains,
the mechanism of triclosan resistance consists on the heterologous duplication of the
triclosan target gene due to the acquisition of an additional fabI allele derived from
Staphylococcus haemolyticus (sh-fabI). In the current work, the genomic sequencing
of 10 of these strains allowed the characterization of two novel composite transposons
TnSha1 and TnSha2 involved in the spread of sh-fabI. TnSha1 harbors one copy of
IS1272, whereas TnSha2 is a 11.7 kb plasmid carrying TnSha1 present either as plasmid
or in an integrated form generally flanked by two IS1272 elements. The target and
mechanism of integration for IS1272 and TnSha1 are novel and include targeting of DNA
secondary structures, generation of blunt-end deletions of the stem-loop and absence
of target duplication. Database analyses showed widespread occurrence of these two
elements in chromosomes and plasmids, with TnSha1 mainly in S. aureus and with
TnSha2 mainly in S. haemolyticus and S. epidermidis. The acquisition of resistance
by means of an insertion sequence-based mobilization and consequent duplication of
drug-target metabolic genes, as observed here for sh-fabI, is highly reminiscent of the
situation with the ileS2 gene conferringmupirocin resistance, and the dfrA and dfrG genes
conferring trimethoprim resistance both of which are mobilized by IS257. These three
examples, which show similar mechanisms and levels of spread of metabolic genes
linked to IS elements, highlight the importance of this genetic strategy for recruitment
and rapid distribution of novel resistance mechanisms in staphylococci.
Keywords: insertion sequence, transposon, antimicrobial drug resistance, metabolism, resistance risk, fabI, IS5
family, IS1182 family
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INTRODUCTION
The NADH-dependent trans-2-enoyl-acyl carrier protein (ACP)
reductase FabI is one of the highly conserved enzymes of the
bacterial fatty-acids biosynthesis. The FabI enzyme has been
recognized as a novel and promising candidate drug target (Payne
et al., 2001; Lu and Tonge, 2008) given the absence of a eukaryotic
orthologue and its essential role in the growth of bacterial cells
(Heath et al., 2001; Ji et al., 2004); a concept recently challenged
by the observation that some bacteria do not require biosynthesis
of fatty acids during infection of the host (Brinster et al., 2009).
Due to the interest in using FabI as a drug target concerns have
been raised about the large scale use of the biocide triclosan
which targets the active site of FabI (Schweizer, 2001; Hijazi et al.,
2016); these concerns also encompass the wider risk that biocide
use per se may have on antimicrobial drug resistance (Oggioni
et al., 2012, 2013, 2015; Coelho et al., 2013; Maillard et al., 2013;
Morrissey et al., 2014). In the specific case considered here the
concern is due to the fact that resistance to triclosan is in most
bacterial species mediated by mutation of the promoter region or
coding sequence of fabI (Heath et al., 1999; Slater-Radosti et al.,
2001; Ciusa et al., 2012; Oggioni et al., 2012; Grandgirard et al.,
2015). In Staphylococcus aureus about half of resistant isolates
have a novel type of triclosan resistance mechanism which is
based on the presence of an alternative copy of fabI derived
from Staphylococcus haemolyticus (sh-fabI) (Ciusa et al., 2012).
In previous work, we reported that the sh-fabI gene appears to be
part of a 3022 bp transposable element most probably mobilized
by a single copy of the insertion sequence (IS) 1272 (Ciusa et al.,
2012). IS1272 was originally identified in S. haemolyticus during
investigation of homology matches to a truncated IS which is part
of the mec cassette (Archer et al., 1994, 1996; Tonouchi et al.,
1994). IS1272 is part of the IS1182 family of insertion sequences
(Siguier et al., 2015) and apart from that truncated version found
in themec element is absent from S. aureus.
It has long been known that IS elements are able to
transpose and/or change the expression of nearby or neighboring
genes, that they are significantly involved in plasmid and
chromosomal recombination, and that they provide the basic
structure of many transposons and mobile resistance elements
(Siguier et al., 2014, 2015). Soon after the discovery of ISs,
it was observed that IS elements were able to transpose
resistance genes between replicons (Hedges and Jacob, 1974;
Barth et al., 1976). Most of the attention in the more recent
sequence based work on antimicrobial resistance has still
focussed on acquired “resistance”-genes which confer resistance
either by target modification, inactivation of the antimicrobial
compound or eﬄux; this is in part due to the difficulty of
defining housekeeping genes identified in high throughput or
metagenomic datasets as true “resistance” genes (Martinez et al.,
2015). All of this “resistance”-gene oriented work has therefore
overshadowed other mechanisms of resistance including those
based on heterodiploidy for a metabolic gene (either resistant or
susceptible alleles) which, especially in staphylococci, appears to
be a mechanism with low fitness cost (Andersson, 2006; Oggioni
et al., 2012). The classic example of such heterodiploidy is the
presence of an additional copy of a dihydrofolate reductase
(dhfA) gene on conjugative elements, which thereby confers
resistance to trimethoprim; these include the plasmid located
dhfA gene which is transposed in E. coli by Tn7 (Barth et al.,
1976), the Tn4003 transposon of S. aureus where the dfrA gene
is mobilized by IS257 (Needham et al., 1995), and the more
recently discovered transposable unit that comprises dfrG and
IS256 which is located on the Tn5801 of different species (León-
Sampedro et al., 2016). A more recent example in S. aureus
involves resistance to mupirocin (pseudomonic acid), a potent
inhibitor of the isoleucyl tRNA synthetase; this is conferred by
an additional plasmid-encoded mupA/ileS2 gene, which is again
mobilized by IS257 (Gilbart et al., 1993; Woodford et al., 1998).
With mupirocin, a disinfectant utilized for skin decontamination
of MRSA staphylococci, this increased occurrence of mupA/ileS
genes in clinical settings where mupirocin was used for
decolonization has led to changes in disinfection policies (Hetem
and Bonten, 2013). Even if the presence of additional mupA/ileS
genes were found to confer a fitness defect to S. aureus, recent
modeling experiments have predicted long-term increases in the
prevalence of mupirocin-resistant phenotypes (MupR) given the
“universal” use of mupirocin (Deeny et al., 2015).
In order to investigate the nature, sequence conservation,
epidemiological distribution, and target site specificity of the
3022 bp transposable element carrying the sh-fabI gene we have
sequenced the genomes of a series of triclosan resistant S. aureus
isolates (Ciusa et al., 2012) and compared these data to the
vast database of published genomes. The aims of this study
were to conduct an in depth characterization of the sh-fabI
carrying element, and to put this work into context with the other
resistance mechanisms in S. aureus also based on IS mobilization
of metabolic genes, which, in this species, appears to be a highly
flexible means for the recruitment and rapid spread of novel
resistance traits.
MATERIALS AND METHODS
Bacterial Strains
Sixty-five S. aureus strains with reduced susceptibility to triclosan
were previously identified by performing standard MIC and
MBC assays upon a collection of 1602 clinical isolates (Ciusa
et al., 2012; Furi et al., 2013; Grandgirard et al., 2015; Oggioni
et al., 2015). Ten out of the 28 isolates carrying the sh-fabI gene
were selected from this collection for this work (Table 1; Ciusa
et al., 2012).
Whole Genome Sequencing and
Bioinformatic Analysis
The entire genome of 10 S. aureus clinical isolates (Table 1)
with reduced susceptibility to triclosan and positive for sh-fabI
detection by PCR were sequenced as previously described
(Ciusa et al., 2012; Table 1). Short reads were assembled
using ABySS (British Columbia Cancer Agency, Vancouver,
Canada; ver. 1.3.5), improved using the multi-reference based
scaffolder MeDuSa (Bosi et al., 2015) and subsequent TnSha1
sequence identification was performed using NCBI’s BLAST.
2.3.0+ (Altschul et al., 1997). The sequence of the prototype
TnSha1 element corresponds to position 3908 to 887 of GenBank
Frontiers in Microbiology | www.frontiersin.org 2 June 2016 | Volume 7 | Article 1008
Furi et al. Is Based Dissemination of Metabolic Resistance Genes
TABLE 1 | Relevant information of the ten sequenced S. aureus isolates (Ciusa et al., 2012).
Strain TnSha1 insertion site MLST Country Year MIC (mg/L) MBC (mg/L) MRSA
QBR-102278-1091 D 12 Japan 2002 4 32 MSSA
QBR-102278-1107 G 1 Australia 2002 4 32 MSSA
QBR-102278-1203 E 1 France 2002 2 16 MSSA
QBR-102278-1619 A 8 Spain 2002 4 32 MSSA
QBR-102278-2092 A2 8 Canada 2003 4 32 MSSA
QBR-102278-2210 F 83 Mexico 2003 1 32 MSSA
QBR-102278-2351 A2, and B 3 Brazil 2003 8 32 MSSA
QBR-102278-2365 C 8 Brazil 2003 2 32 MSSA
QBR-102278-2376 C 8 Argentina 2003 4 32 MSSA
QBR-102278-2605 A2 8 Japan 2003 32 64 MRSA
accession JQ712986 relative to S. aureus strain QBR-102278-
1619. No complete sequence of TnSha2 is present in existing
complete genomes in GenBank. One of the plasmid versions of
TnSha2, which shows a contig break within fabI, corresponds
to GenBank accession JCAZ01000023 of S. aureus strain
M0227 (adzpz-supercont1.20.C23). Genbank BLAST searches for
TnSha1 and TnSha2 elements were last accessed in December
2015. DNA secondary structures have been predicted by
means of the RNAstructure Web Server (Reuter and Mathews,
2010). TnSha1 targets A through G have been confirmed
as gene terminator loops by direct visualization of RNA-
seq alignment data retrieved from the NCBI Sequence Read
Archive (SRA; http://www.ncbi.nlm.nih.gov/Traces/sra/). More
precisely Illumina HiSeq data which were previously generated
by sequencing of whole RNA (rRNA depleted) extracted from
S. aureus ATCC51811 (SRA Experiment ID: ERP005246; SRA
Sample ID: ERS421566) (Fagerlund et al., 2014) were aligned to
genomes of S. aureus COL, GenBank accession no. CP000046,
and S. aureus MW2, GenBank accession no. BA000033, using
BWA-MEM (Li, 2014). The bootstrap maximum likelihood
tree was obtained using MEGA6 with default parameters.
Sequence Types (ST) were defined using theMultilocus Sequence
Typing (MLST) web-based service of the Center for Genomic
Epidemiology (Lyngby, Denmark; MLST allele sequence and
profile data were obtained from: http://pubmlst.org/; Larsen
et al., 2012). Contigs containing the TnSha2 element were
screened to identify plasmid sequences by means of the
PlasmidFinder web-based service of the Center for Genomic
Epidemiology (Ver. 1.3; Lyngby, Denmark).
Molecular Analysis of Potential Transfer
Intermediates
Genomic DNA was extracted from S. aureus strains in the
exponential phase of growth using the High Pure PCR template
preparation kit (Roche Diagnostics, Germany). Prior to DNA
purification the bacterial strains were grown in MHB (Muller
Hinton Broth; Beckton Dickinson) in the presence of sub-MIC
concentrations of triclosan (2mg/L for strain QBR-102278-1619
and 4mg/L for QBR-102278-2351) or following Mitomycin C
induction (1 µg/L) (triclosan PHR1338; Sigma-Aldrich) (Ciusa
et al., 2012; Oggioni et al., 2012). Negative controls grown in
MHBmedium only were also used. A FAM labeled TaqMan probe
was designed to detect the circular form of the IS1272 and the
composite transposon TnSha1 when both were excised from the
chromosome (Table 2). Detection of strains carrying TnSha1 in
either the A or B integration sites via real-time PCR amplification
was performed in a LightCycler 480 system (Roche Diagnostics,
Germany) using primers annealing between the integration site
and the transposon (Table 2; Oggioni et al., 2002; Isola et al.,
2005; Yesilkaya et al., 2006). Primers LF_30 and LF_31 were
used to detect the presence of bacteria with a transposon free
integration site A (Table 2).
RESULTS
We have recently reported that a 3022 bp chromosomal element
composed of the insertion sequence IS1272 and a fabI gene of S.
haemolyticus (sh-fabI) confers resistance to triclosan in S. aureus
(Figure 1A; GenBank accession no. JQ712986) (Ciusa et al.,
2012). The potential for transposition of this unit is conferred
by the presence of an alternative inverted repeat (IRL’) in the
S. haemolyticus chromosome upstream of sh-fabI with a high
degree of similarity to the inverted repeats of IS1272 (Figure 1B).
This functional unit, which is composed of the insertion sequence
IS1272 and the sh-fabI gene, has now being renamed TnSha1
(Figure 1A). It should be noted that none of our genomes,
nor any deposited sequence, match the originally deposited
sequence of IS1272 (Genbank accession U35635), instead all of
the hundreds of IS1272 copies show at least six SNPs (four of
which are indels) with respect to U35635 (Archer et al., 1996).
These differences mean that the updated IS1272 element encodes
for a single transposase gene without a stop codon (Figure 1A).
In this work the sequence conservation, epidemiological
distribution, and target site specificity of TnSha1 were analyzed
across a panel of ten sequenced S. aureus strains previously
reported to carry the sh-fabI gene (Ciusa et al., 2012). Sequencing
has identified seven different integration sites within the S.
aureus genomes which have been named A through G (Figure 2,
Table 1). The discovery of seven different TnSha1 integration
sites in just 10 strains suggests that there is little or no insertion
site preference. Analysis of the intact target sites in the reference
strains COL or MW2 showed that TnSha1 integration always
Frontiers in Microbiology | www.frontiersin.org 3 June 2016 | Volume 7 | Article 1008
Furi et al. Is Based Dissemination of Metabolic Resistance Genes
FIGURE 1 | Structure of the TnSha1 transposon. The schematic map of the composite transposon TnSha1 in which the sh-fabI gene (black) precedes the IS1272
element is shown in panel (A). The updated IS1272 sequences contains six SNPs (four of which indels) with respect to U35635 and encodes for a single transposase
gene without a stop codon within the IS element. The sequence of the prototype TnSha1 element corresponds to position 3908 to 887 of Genbank accession
JQ712986 relative to strain QBR-102278-1619. Panel (B) shows the inverted repeat sequences of IS1272 (named IRL and IRR) aligned to the IRL’ upstream of
sh-fabI which shows 69% identity. Panel (C) indicates the hypothesized integration event of IS1272 downstream of sh-fabI to generate the prototype TnSha1 element
in S. haemolyticus. The arrow indicates the insertion point at the base of the sh-fabI terminator hairpin.
TABLE 2 | List of primers.
Name Position (GenBank ID) Sequence
LF_26 Taqman probe for TnSha1
(JQ712986)
6FAM-TTCACTTATCCAAGA
ACTTTATGTCCCGGA-BHQ-1
LF_27 IRL’ of TnSha1 (JQ712986) ATCCTTGCCGGGGTAAT
ACAAC
LF_28 IRL of TnSha1 (JQ712986) AAAGCGAGCCAACAATACG
GAGTA
LF_29 IRR of TnSha1 (JQ712986) TAGTAGCTCAACGAGCTGA
AAATAATC
LF_30 Upstream region flanking the TnSha1
integration site A/A2 (NC_002951)
TTGATTTATTTCCCAGCCTATT
CTTTTCA
LF_31 Downstream region flanking the TnSha1
integration site A/A2 (NC_002951)
AGGATGTCGATTTGATTTAT
ATTTTTTGTACAT
LF_32 Downstream region flanking the
TnSha1 integration site B (NC_002951)
ATCATTTCGTTTATATATAGCA
GACATGATAGA
occurs into hairpin structures and, importantly, that the mode
of insertion of TnSha1 always produces a partial deletion of the
target sequence (Figure 2B). This mode of integration into the
stem of secondary structures is novel to IS elements (Siguier
et al., 2015). For one of the targets sequenced in this work there
were two different transposition events which could be detected;
these lead to deletions of different sizes in the same target site
(A and A2; Figure 2B). All seven of the target sites identified
by sequencing of our clinical isolates, in addition to other sites
subsequently identified in published sequences, were composed
of inverted repeat sequences and thus have the potential to form
secondary structures with the repeats representing the stems of
hairpins (Figure 2A). In each case insertion of TnSha1 produced
a partial deletion of the hairpin. This type of cleavage of a
secondary structure forming sequences appears to indicate that
TnSha1 makes blunt and not staggered cuts, which would have
resulted in target duplications. Hairpins A through E have been
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FIGURE 2 | Insertion sites of TnSha1 in bacterial chromosomes and plasmids. The seven target sites found in the 10 S. aureus strains sequenced in this work
have been named from A to G. Staphylococcal plasmid insertion sites are named P to Z. Panel (A) shows the hairpin structures formed by the transposon target sites
and the scissors indicate the position of sequence breaks generated upon TnSha1 insertion. Secondary structure predictions were made using RNAstructure
web-based software (Reuter and Mathews, 2010). Two independent insertions into target (A) have been identified and both cleavage sites are shown which in each
case generate blunt-end structures in the stem of the hairpin. The sequences in both panels (A,B) refer to TnSha1-free target sites in the chromosomes (COL
GenBank accession CP000046 and MW2 GenBank accession BA000033) and plasmids. The target sequences in panel (B) report in lower case the sequence
deleted upon insertion and the inverted repeats underlined. Panel (C) shows evidence for multiple insertions of TnSha1 in target Z in the repA terminator of plasmids.
The aligned sequences show at least four independent insertions in two opposite orientations of TnSha1 into the repA terminator in plasmid pUSA03 (target Z). In this
panel TnSha1 sequences are shown in bold italics upper case, the deleted part of the target sequence in lower case, and the repA terminator hairpin underlined. Note
that in panel (C) the upper four TnSha1 sequences are in one orientation while the lower three in the opposite orientation. Note that in panel (C) the upper four
TnSha1 sequences are in one orientation while the lower three in the opposite orientation. The S. aureus strain names are given on the right.
confirmed as transcriptional terminators by mapping of RNAseq
data (Fagerlund et al., 2014; Figure 3). When analysing the target
sites of a further 63 complete TnSha1 elements from published
S. aureus genomes, we identified an additional 12 target sites
confirming a lack of any primary sequence specificity within
the target. All of the aforementioned features of TnSha1 are
consistent with the known behavior of the IS1272 element alone
(Archer et al., 1996); i.e., such as the insertion of IS1272 which
occurred into the terminator of sh-fabI to generate the prototype
TnSha1 (Figure 1C), or as in the case of two target sites selected
from IS1272 insertions in the genomes of S. haemolyticus or
S. warneri (Figure 4). While most sequenced strains contained
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FIGURE 3 | The seven TnSha1 integration sites found in the sequenced S. aureus clinical isolates mapped onto annotated genomes. The S. aureus
reference genomes included COL (GenBank accession no. CP000046; A–C insertion sites), JKD6159 (GenBank accession no. CP002114; D insertion site), and
MW2 (GenBank accession no. BA000033; E,F insertion sites). 3/7 TnSha1 elements target predicted terminator hairpin structures (C–E), 1/7 targets the agrC coding
region (G), and 3/7 target intergenic regions (A,B,F). Hairpins (A) through (E) have been confirmed as transcriptional terminators by mapping RNAseq data.
just a single copy of TnSha1 in the chromosome, strain QBR-
102278-2351 was an exception and carried two TnSha1 elements
each in two distinct integration sites (Figure 2, Table 1).
The dynamics and epidemiology of transposition between
strains was addressed by searching for other TnSha1 elements
present in Genbank. Database searches identified 133 complete or
partial TnSha1 elements in the genomes of the species S. aureus,
S. argenteus, S. haemolyticus, S. epidermidis, S. saprophyticus,
and S. warneri, and in a series of staphylococcal plasmids
(Tables 3–5). Of this latter group the integration between repA
and IS257 in pUSA03 (target Z in Table 4) where TnSha1
was inserted in two different orientations warrants particular
attention (Figure 2C). Multi locus sequence typing (MLST) of
the strains showed that TnSha1 was present in S. aureus in
sequence type 8 (n = 23), ST5 (n = 18), ST239 (n = 6), and
ST290 (n = 6) strains and in S. epidermidis in ST59 (n = 10)
and ST2 (n= 6) strains (Table 4, Figure 5). Upon determination
of the targets of these newly identified TnSha1 elements it was
found that only seven out of the 66 complete TnSha1 elements
were integrated into the same seven target sites, A to G, that we
had previously identified (Figure 2, Tables 1, 4). Alignment of
our previous 10 TnSha1 elements with the seven new TnSha1
elements that were integrated at the same target sites showed
clustering of the TnSha1-SNPs (some elements differed by up
to 11 SNPs from the consensus) together with their target sites
(Figure 6). This pattern is consistent with the insertion of the
element into a particular target followed by clonal spread. This
scenario appears to be the rule in most cases except for target A2
and Z where the identical TnSha1 element is present in the same
target but in strains of different ST (Table 4, Figure 5). To test for
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FIGURE 4 | Analysis of target sites of IS1272 in S. warneri and S. haemolyticus. Secondary structure predictions of the IS1272 targets in the S. warneri strain
SG1 (GenBank accession CP003668) are shown in the IS free reference strain VCU121 (GenBank accession NZ_AFEC01000030) (A left); and in the S. haemolyticus
strain Sh29/312/L2 (GenBank accession CP011116) are shown in the IS free reference strain R1P1 (GenBank accession NZ_AJVA00000000) (A right). The exact
blunt target cleavage sites are indicated by scissors. Panel (B) indicates the target sequences showing the inverted repeats (underlined) and deletions (lower case).
TABLE 3 | BLAST search of staphylococcal genomes for TnSha1 and TnSha2.
Species Element Chromosomal* Plasmid** Total Total number of genomes %
S. argenteus TnSha1 1 1 2 6 33
TnSha2 – – – –
S. aureus TnSha1 61 3 64 4127 1.5
TnSha2 1 – 1 0.02
S. epidermidis TnSha1 30 1 31 286 10.8
TnSha2 19 – 19 6.6
S. haemolyticus TnSha1 3 – 3 141 2.1
TnSha2 10 – 10 7
S. warneri TnSha1 2 – 2 7 28.6
TnSha2 – – – –
S. saprophyticus TnSha1 1 – 1 5 20
TnSha2 – – – –
Total 128 5 133 4567 –
*The localization designated as chromosomal may also include plasmids present in genome contigs. **Only includes plasmids deposited as complete plasmids.
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TABLE 4 | List of strains carrying the TnSha1 element on the chromosome.
Species GenBank ID Strain name Insertion MLST
site
S. argenteus CCEM01000001 Sa_LBSA043 M –
S. aureus AIDT01000009 DR10 H 398
S. aureus AUPV01000018 S100 H 398
S. aureus CAVU010000033 S1805 E 80
S. aureus CAWA010000053 S2396 E 1
S. aureus CFPN01000018 USFL079 L 8
S. aureus CGGX01000004 USFL145 A 8
S. aureus CIAK01000002 USFL234 J 8
S. aureus CIGG01000001 USFL129 C 8
S. aureus CP003045 71193 H 398
S. aureus CSDA01000011 USFL101 L 8
S. aureus CSDP01000002 USFL046 J 8
S. aureus CSEJ01000001 USFL123 C 8
S. aureus CSEV01000003 USFL189 A2 828
S. aureus CSFL01000012 USFL078 L 8
S. aureus CSHX01000003 USFL190 A2 828
S. aureus CSJZ01000023 USFL050 nd 8 slv*
S. aureus CTWU01000023 M705 K 239
S. aureus CTWW01000088 H211 K 239
S. aureus CTXO01000001 M1229 K 239
S. aureus CTXZ01000061 H216 K 239
S. aureus CTYD01000081 H202 K 239
S. aureus CVOP01000018 SH3 M 630
S. aureus CVOU01000018 SH1 M 630
S. aureus CVRW01000028 M170 K 239
S. aureus JBFG01000011 KINW6058 I 5
S. aureus JBGB01000006 FVRH6130 nd 8
S. aureus JBGS01000014 GGMC6026 I 5
S. aureus JBLE01000006 SCOA6048 H 8
S. aureus JBMX01000012 SCOA6012 H 8
S. aureus JDLS01000019 T78544 I 5
S. aureus JDOK01000060 F35307 nd 5
S. aureus JDOU01000017 H27862 I 5
S. aureus JDOV01000017 H27872 I 5
S. aureus JDPI01000020 H67656 I 5
S. aureus JECS01000014 T34011 I 5
S. aureus JEDV01000017 H64967 I 5
S. aureus JETJ01000039 T22051 nd 5
S. aureus JGNE01000030 W41757 nd 5
S. aureus JHTT01000046 CO-86 L 8
S. aureus JIXI01000011 PA57 H 398
S. aureus JIYX01000004 C5086 H 398 slv
S. aureus JJDE01000001 122 H 398
S. aureus JURB01000090 84_SAUR F 5
S. aureus JUTG01000033 78_SAUR F 5
S. aureus JVUC01000150 1315_SAUR nd 15
S. aureus JZAL01000002 LHSKBClinical C 8
S. aureus LAMP01000014 99-06 L 8
S. aureus LAMS01000038 99-48 L 8
S. epidermidis ACHE01000003 BCM-HMP0060 – 59
(Continued)
TABLE 4 | Continued
Species GenBank ID Strain name Insertion MLST
site
S. epidermidis AGUC01000094 14.1.R1.SE – –
S. epidermidis AHLC01000060 VCU120 – 22
S. epidermidis AHLF01000017 VCU125 – 384
S. epidermidis AKGM01000041 NIHLM067 – 333
S. epidermidis AKGN01000056 NIHLM061 – 332
S. epidermidis AKGW01000049 NIHLM020 – 7
S. epidermidis APHT01000038 528m – 2
S. epidermidis APHU01000037 41tr – 2
S. epidermidis ARWU01000031 UC7032 – 595
S. epidermidis JUMV01000141 938_SEPI – 59
S. epidermidis JUNI01000550 926_SEPI – 59
S. epidermidis JUVK01000069 73_SEPI – 16
S. epidermidis JUYJ01000034 655_SEPI – 59
S. epidermidis JUYK01000190 654_SEPI – 59
S. epidermidis JVQK01000079 196_SEPI – 59
S. epidermidis JVSC01000077 154_SEPI – 59
S. epidermidis JVSC01000077 154_SEPI – 59
S. epidermidis JVSZ01000046 134_SEPI – 59
S. epidermidis JVTV01000122 1321_SEPI – 59
S. epidermidis JWBR01000039 114_SEPI – –
S. epidermidis JWCR01000091 1115_SEPI – 88
S. epidermidis JWEH01000024 1063_SEPI – 2
S. epidermidis JWFU01000070 1024_SEPI – 2
S. epidermidis JWFV01000104 1023_SEPI – 2
S. epidermidis JZUK01000044 NGS-ED-1107 – 2
S. epidermidis JZUL01000024 NGS-ED-1109 – 439
S. haemolyticus CP011116 Sh29/312/L2 – –
S. haemolyticus CUEZ01000014 CN1197 – –
S. saprophyticus JXBG01000015 SU8 – –
S. warneri CANQ01000015 A487 – –
S. warneri JPOW01000002 NGS-ED-1001 – –
*slv = single locus variant; targets A–G from our genome sequences; targets H–Z from
Genbank, nd not determined.
TnSha1mobilization we used PCRwith a set of divergent primers
on TnSha1, another set on IS1272, and a third set of primers
targeting the “A” insertion site. Unfortunately, no excision events
producing a circular intermediate could be observed when two
S. aureus strains were tested with or without the presence
of triclosan in the culture medium, and after induction with
mitomycin C.
Within the multiple entries retrieved from Genbank a
subgroup showed identical sequences upstream of TnSha1.
Investigation of this genomic region showed that in 30 of the
strains the TnSha1 element forms part of a larger element (named
TnSha2), which in almost all cases is a plasmid, but which can
also be found integrated into the genome where it is generally
flanked by a second copy of IS1272 (Tables 4, 5). The prototype
sequence of TnSha2 (S. aureus JCAZ01000023) is an 11.7 kb
plasmid in which TnSha1 is inserted into the terminator of
traQ gene of an 8.7 kb replicon (without fabI and IS1272)
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TABLE 5 | List of strains carrying the TnSha1 element on a plasmid.
Species GenBank ID Strain name Plasmid Insertion site MLST
S. argenteus FR821778 MSHR1132 pST75 X2 –
S. aureus AHVE01000013 CIG1165 Plasmid X 5
S. aureus CP012121 USA300_2014.C02 pUSA300_2014.C02 X 8
S. aureus CP012594 HOU1444-VR pVR-MSSA_01 W 5
S. aureus CSBT01000019 USFL338 Plasmid V 8
S. aureus JBGG01000015 LAMC6115 Plasmid Zrc 8
S. aureus JBJX01000010 SJUD6114 Plasmid X 8
S. aureus JBRD01000004 AMMC6015 Plasmid Z 8
S. aureus JBSH01000015 HOAG6084 Plasmid Z 8
S. aureus JCAZ01000023 M0227 TnSha2 P 5
S. aureus JDXZ01000007 LPIH6008 Plasmid Z 8
S. aureus JEEN01000028 F77919 Plasmid Z 5
S. aureus JEOI01000012 W21479 Plasmid Z 5
S. aureus JEQM01000030 F70077 Plasmid Zrc 5
S. aureus JGFR01000050 F12753 Plasmid Zrc 5
S. aureus JGIT01000028 T28653 Plasmid X 8
S. aureus JICL01000103 880 pHMPREF1625_3 W –
S. aureus JVUX01000076 1299_SAUR Plasmid Z 2250
S. epidermidis GQ900465 SK6536 pSAP110A Y –
S. epidermidis JUPD01000185 890_SEPI TnSha2 P 2
S. epidermidis JUUP01000151 749_SEPI TnSha2 P 2
S. epidermidis JUYI01000150 656_SEPI TnSha2 P 2
S. epidermidis JUZG01000070 634_SEPI TnSha2 P 2
S. epidermidis JUZR01000081 623_SEPI TnSha2 P 2
S. epidermidis JVBT01000060 568_SEPI TnSha2 P 2
S. epidermidis JVHA01000086 439_SEPI TnSha2 P 2
S. epidermidis JVHR01000056 422.rep2_SEPI TnSha2 P 2
S. epidermidis JVHS01000079 422.rep1_SEPI TnSha2 P 2
S. epidermidis JVKK01000090 354_SEPI TnSha2 P 2
S. epidermidis JVXB01000116 1249_SEPI TnSha2 P 2
S. epidermidis JWBN01000071 1143_SEPI TnSha2 P 2
S. epidermidis JWDK01000004 1088_SEPI TnSha2 P 2
S. epidermidis JWFS01000043 1026_SEPI TnSha2 P 2
S. epidermidis JWFW01000102 1022_SEPI TnSha2 P 2
S. epidermidis JWFX01000149 1021.rep2_SEPI TnSha2 P 2
S. epidermidis JWFY01000144 1021.rep1_SEPI TnSha2 P 2
S. epidermidis JWGH01000004 1013_SEPI TnSha2 P 2
S. epidermidis JWGL01000037 101_SEPI TnSha2 P 2
S. haemolyticus CUCK01000025 25-38 TnSha2 in chromosome* P 29
S. haemolyticus CUCN01000051 25-60 TnSha2 P –
S. haemolyticus CUCZ01000051 51-13 TnSha2 P 3
S. haemolyticus CUDB01000007 51-11 TnSha2 in chromosome P 3
S. haemolyticus CUDQ01000054 51-33 TnSha2 P 3
S. haemolyticus CUDW01000051 51-41 TnSha2 P 2
S. haemolyticus CUDY01000029 51-43 TnSha2 in chromosome P 2
S. haemolyticus CUFB01000040 51-15 TnSha2 P 3
S. haemolyticus CUGD01000039 127925 TnSha2 in chromosome P 3
S. haemolyticus CUGG01000054 113101 TnSha2 P 3
*Chromosomally integrated TnSha2 elements are reported for clarity in this plasmid table.
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FIGURE 5 | Phylogram of the TnSha1 and TnSha2 elements. The tree
contains 57 TnSha1 sequences, 10 of which sequenced in this work
(QBR-102278 sequences) and a subset of eight TnSha2 sequences (only the
homologous part was used for tree building purposes). Each TnSha1 element
is identified by its target (A–Z), followed by the sequence type (ST), and the
strain name. TnSha1 elements on S. aureus plasmids are colored in green
while TnSha2 elements are in blue. For GenBank accession numbers please
see Tables 1, 4. The bootstrap maximum likelihood tree was obtained using
MEGA6 with default parameters. The scale bar is shown in the upper left part.
It should be noted that the tree is built based on only few SNPs, which
distinguish the different elements.
FIGURE 6 | MLST profiles of staphylococcal strains carrying TnSha1
and TnSha2. The sequence type (ST) of 62 S. aureus (A) and 47
S. epidermidis strains (B) which carry the sh-fabI elements TnSha1 (filled bars)
and TnSha2 (open bars) are shown. Data are from staphylococcal genomes
accessed in GenBank in December 2015 and sequence types were defined
using the MLST web-service of the Center for Genomic Epidemiology (Larsen
et al., 2012).
present in S. haemolyticus (CUCL01000044), but also in S. aureus
(JJAQ010000025; Figure 7). The rep of the plasmid belongs to
the Rep_2 family and the DNA polymerase, recombinase and
mobilization protein show high sequence identity to those of
plasmid p-12228-03 of the S. epidermidis reference strain ATCC
12228 (Figure 7; Zhang et al., 2003; Lanza et al., 2015). ThSha2
was detected in the genomes of clonally diverse S. haemolyticus,
and S. epidermidis (ST3 n = 6, and ST2 n = 21, respectively),
but only in a single S. aureus (ST5) genome, thereby reflecting
different dissemination routes for different species (Table 5).
Upon investigating the origin of deposited genome-strains it was
observed that the S. epidermidis ST2 strains are of hospital origin
(Schoenfelder et al., 2010; Roach et al., 2015) and that all of the
S. haemolyticus strains with TnSha2 and ST3 that we found in
this study are clinical isolates (Table 5). Interestingly the database
search for IS1272 alone detected no intact elements in S. aureus,
but did show that about 1/10 of S. epidermidis isolates and
the majority of S. haemolyticus isolates carried IS1272 thereby
ensuring that the contigs with the 11.7 kb plasmid in these species
are always interrupted in the IS element.
In a phylogenetic tree based on the TnSha1-part of TnSha2,
the two elements group into separate branches due to a series
of SNPs both in fabI and the IS1272 element (Figure 5). In
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FIGURE 7 | Schematic map of TnSha2 elements. The circular maps of the prototype 11.7 kb plasmid sequence of TnSha2 (S. aureus strain M0227, GenBank
accession JCAZ01000023) and the target 8.7 kb TnSha1-free plasmid (S. haemolyticus CUCL01000044 or S. aureus JJAQ010000025) are shown in panel (A). The
map of TnSha2 integrated into the S. haemolyticus chromosome at a position occupied by a single IS1272 in the reference strain is shown in panel (B). In three
occasions the resulting chromosomal island is bordered by two IS1272 elements (CUCK01000025 at position 590129 of strain JCSC1435, CUDY01000029 at
1828271, and CUGD01000039 at 2443315) wile in one case only by the “left” IS1272 element (CUDB01000007 at 1322312). Comparison between pTnSha2
element (S. aureus JCAZ01000023) and pSE-12228-03 (S. epidermidis NC_005006) is shown in panel (C). Numbers between brackets indicate coverage percentage
and identity percentage respectively. The genes encode for: a putative DNA-directed DNA polymerase (DNA pol), a replication protein involved in a theta-type
replication mechanism (Rep), a putative mobilization protein (Mob), a domain of a group of polymorphic toxin proteins (LXG), a Site-specific DNA recombinase related
to the DNA invertase Pin (PinE), and a conjugal transfer pilin chaperone (TraQ).
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four cases the whole 11.7 kb TnSha2 plasmid appears to be
integrated into the chromosome of S. haemolyticus in the same
position that IS1272 elements are found in reference strain
JCSC1435 resulting in a chromosomal island flanked in three
cases by two IS1272 copies (CUCK01000025 at position 590.150
of JCSC1435, CUDB01000007 at 1.322.311, CUDY01000029 at
1.828.279, and CUGD01000039 at 2.443.339; Figure 7; Cavanagh
et al., 2014).
In the original publication, which described sh-fabI in
S. aureus QBR-102278-1619 (Ciusa et al., 2012), the TnSha1
element was reported to carry a sh-fabI gene with an A577T
SNP with respect to the sequence of the core genome fabI of
S. haemolyticus (Table 6). Since, this SNP had not previously been
associated with triclosan resistance of sa-fabI in S. aureus the gene
was reported to represent a susceptible allele (Ciusa et al., 2012).
Whilst analysing the panel of sh-fabI genes carried by TnSha1
these were all found to show at least one SNP compared to
the core-genome triclosan-susceptible sh-fabI of S. haemolyticus
(Table 6). All of these SNPs, except A577T and T578A (see
above), have previously been associated with triclosan resistance
in the S. aureus sa-fabI (Table 6; Ciusa et al., 2012; Grandgirard
et al., 2015). The only exception is S. aureus strain T22051 which
carried a wild type sh-fabI gene in TnSha1 thus indicating that
the second (or third) IS-element mobilized genomic fabI copy
generally appears to be a resistant allele.
DISCUSSION
A novel mobile chromosomal element based upon IS1272 and
containing the sh-fabI gene of S. haemolyticus has been identified
in a large-scale screen for biocide resistance across more than
1600 S. aureus isolates (Ciusa et al., 2012). This element, now
named TnSha1, had been found to be present in one third of
triclosan resistant strains of S. aureus while the other triclosan
resistant strains of that study had mutations either within or
upstream of the enoyl-acyl carrier protein reductase fabI gene
of the core genome (Ciusa et al., 2012; Grandgirard et al., 2015).
A more detailed analysis of these S. aureus strains, and of other
available staphylococcal genomes, has shown that the situation is
actually more complex. The main finding of this was that sh-fabI
appears to be transferred by two types of elements; TnSha1, which
has a single IS1272 element, and the composite TnSha1-carrying
plasmid TnSha2 which can also integrate into chromosomal
IS1272 copies generating in most cases an IS1272 bordered island
(Figures 1, 7). Similar congruent formations where reported
for other similar elements as for example IS257 mobilizing
the trimethoprim resistance determinant dfrA (Leelaporn et al.,
1996). As the two elements do not show any obvious species
specific characteristics it was somewhat unexpected to observe
such a strong divergence in distribution for these elements, with
S. aureus almost exclusively harboring TnSha1, S. haemolyticus
prevalently harboring TnSha2, and only S. epidermidis which
was found to commonly carry both elements. Neither the
GC content (TnSha1 is 31.4%, TnSha2 is 31.8%, S. aureus, S.
haemolyticus 33%, and S. epidermidis 32%), nor the presence of
restriction modification systems nor the origin of the isolates
can explain this observation; however we admit that this is as
yet based on 4127 S. aureus genomes, but upon just 286 S.
epidermidis and 141 S. haemolyticus genomes. Similar dynamics
are seen with trimethoprim resistance were the housekeeping
dfrA gene was acquired from other species and successfully
transferred by IS257 across different staphylococcal species (Dale
et al., 1995; Leelaporn et al., 1996). Whilst not explaining
this difference as such, the observation that the intact IS1272
elements are present in most S. haemolyticus isolates, only in
a few S. epidermidis strains and not at all in S. aureus already
indicates a species specific “behavior” of the IS element. Future
experiments on the transposition of the elements in the three
species, will hopefully be more successful than the attempted
detection of circular intermediates in S. aureus and therefore
shed light on the observed differences in the epidemiology of the
elements.
The mechanism of TnSha1 and IS1272 target recognition and
integration appears to be novel. Both TnSha1 and IS1272 are
seen to target hairpin secondary structures with little primary
sequence conservation. In addition this insertion into the target
appears to produce a blunt-end cut leading to insertion of the
element and deletion of part of the target (Figures 1–4). This is
in line with the original description of IS1272 which reported that
the IS did not produce target duplications (Archer et al., 1996).
Interestingly the recent review on IS elements by Siguier and
colleagues reports that some members of the IS1182 family, of
which IS1272 is part, also target palindromic sequences (Siguier
et al., 2015).
Albeit that no primary sequence consensus was detected, the
hairpin structures targeted by TnSha1 must have some important
features in common as we found three targets with evidence
for multiple independent insertions i.e., the targets “A” and “X”
or the target “Z” where we also observed multiple insertions
in both orientations (Figure 2C). The absence of insertion into
rolling circle replicating plasmids, coupled to the observation of
insertions in opposite directions appear to indicate the absence
of an orientation bias observed for IS elements inserting into the
replication fork (Siguier et al., 2014). In the case of TnSha2 the
situation appears to be more varied. The few available data show
that TnSha2 can integrate like IS1272. In addition the few and
incomplete genomic data we have could indicate that TnSha2
could be mobilized by the hypothetical ORFs present leading to
duplications and co-integrate formation (Needham et al., 1995).
The capacity to utilize different integration mechanisms has been
described also for other transposons like Tn7 (Siguier et al.,
2014).
The large number of both TnSha1 and TnSha2 element
sequences available in the database has allowed us to investigate
the genesis of this recently generated and spreading element. This
was hampered in part by the fact that both elements included
IS1272 and that these ISs, like most other repeat sequences,
tend to generate contig breaks during the assembly of bacterial
genomes. Given the absolute conservation of the position of
IS1272 in all of the TnSha1 and TnSha2 elements, we favor
the hypothesis that the initial steps leading to the formation of
these mobile elements were very few or possibly even only a
single event. The initial events in the assembly of the element
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TABLE 6 | Sh-fabI nucleotide sequence of 89 TnSha1 and TnSha2 elements.
Species Strain Polymorphic sites in sh-fabI* Phenotype** Comment
1 5 5 5 6
8 0 7 7 9 1
1 6 7 8 3 1
S. haemolyticus JCSC1435 T G A T C T S Reference strain***
S. haemolyticus 0281 . . . . . . S Triclosan susceptible clinical isolate***
S. aureus T22051 . . . . . . S wt sequence
S. aureus KINW6058 C . T . . . R GTA81GCA V27A; ATT577TTT I193F
S. epidermidis 354_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 422.rep1_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 422.rep2_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 493_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 568_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 623_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 634_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 656_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 749_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 890_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 1013_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 1021.rep2_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 1022_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 1088_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. epidermidis 1143_SEPI . A . . . C R GTT106ATT V36I; TC611TCC F204S
S. aureus F12753 . . T . . . ATT577TTT I193F
S. aureus F70077 . . T . . . ATT577TTT I193F
S. aureus GGMC6026 . . T . . . ATT577TTT I193F
S. aureus H27862 . . T . . . ATT577TTT I193F
S. aureus H27872 . . T . . . ATT577TTT I193F
S. aureus H64967 . . T . . . ATT577TTT I193F
S. aureus H67656 . . T . . . ATT577TTT I193F
S. aureus pHMPREF1625_3 . . T . . . ATT577TTT I193F
S. aureus pVR_MSSA_01 . . T . . . ATT577TTT I193F
S. aureus QBR-102278-1619 . . T . . . ATT577TTT I193F
S. aureus T34011 . . T . . . ATT577TTT I193F
S. aureus T78544 . . T . . . ATT577TTT I193F
S. aureus USFL050 . . T . . . ATT577TTT I193F
S. aureus USFL145 . . T . . . ATT577TTT I193F
S. epidermidis 134_SEPI . . T . . . ATT577TTT I193F
S. epidermidis 154_SEPI . . T . . . ATT577TTT I193F
S. epidermidis 196_SEPI . . T . . . ATT577TTT I193F
S. epidermidis SAP110A . . T . . . ATT577TTT I193F
S. aureus F77919 . . . A . . ATT578AAT I193N
S. aureus LPIH6008 . . . A . . ATT578AAT I193N
S. aureus W21479 . . . A . . ATT578AAT I193N
S. aureus QBR-102278-1203 . . . . G . R GCT593GGT A198G
S. aureus S1805 . . . . G . R GCT593GGT A198G
S. aureus S2396 . . . . G . R GCT593GGT A198G
S. argenteus pST75 . . . . . G R TTC611TGC F204C
S. argenteus Sa_LBSA043 . . . . . G R TTC611TGC F204C
S. aureus 122 . . . . . G R TTC611TGC F204C
S. aureus 1299_SAUR . . . . . G R TTC611TGC F204C
(Continued)
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TABLE 6 | Continued
Species Strain Polymorphic sites in sh-fabI* Phenotype** Comment
1 5 5 5 6
8 0 7 7 9 1
1 6 7 8 3 1
S. aureus 1315_SAUR . . . . . G R TTC611TGC F204C
S. aureus 71193 . . . . . G R TTC611TGC F204C
S. aureus 78_SAUR . . . . . G R TTC611TGC F204C
S. aureus 84_SAUR . . . . . G R TTC611TGC F204C
S. aureus C5086 . . . . . G R TTC611TGC F204C
S. aureus CO-86 . . . . . G R TTC611TGC F204C
S. aureus H202 . . . . . G R TTC611TGC F204C
S. aureus H216 . . . . . G R TTC611TGC F204C
S. aureus LHSKBClinical . . . . . G R TTC611TGC F204C
S. aureus M1229 . . . . . G R TTC611TGC F204C
S. aureus QBR-102278-1091 . . . . . G R TTC611TGC F204C
S. aureus QBR-102278-1107 . . . . . G R TTC611TGC F204C
S. aureus QBR-102278-2210 . . . . . G R TTC611TGC F204C
S. aureus QBR-102278-2365 . . . . . G R TTC611TGC F204C
S. aureus QBR-102278-2376 . . . . . G R TTC611TGC F204C
S. aureus SH1 . . . . . G R TTC611TGC F204C
S. aureus SH3 . . . . . G R TTC611TGC F204C
S. aureus USA300_2014.C02 . . . . . G R TTC611TGC F204C
S. aureus USFL046 . . . . . G R TTC611TGC F204C
S. aureus USFL123 . . . . . G R TTC611TGC F204C
S. aureus USFL129 . . . . . G R TTC611TGC F204C
S. aureus USFL234 . . . . . G R TTC611TGC F204C
S. epidermidis 1249_SEPI . . . . . G R TTC611TGC F204C
S. epidermidis 14.1.R1.SE . . . . . G R TTC611TGC F204C
S. epidermidis NIHLM020 . . . . . G R TTC611TGC F204C
S. haemolyticus Sh29/312/L2 . . . . . G R TTC611TGC F204C
S. aureus QBR-102278-2092 . . . . . C R TTC611TCC F204S
S. aureus QBR-102278-2351 . . . . . C R TTC611TCC F204S
S. aureus QBR-102278-2605 . . . . . C R TTC611TCC F204S
S. aureus M0277 . . . . . C R TTC611TCC F204S
S. aureus USFL189 . . . . . C R TTC611TCC F204S
S. aureus USFL190 . . . . . C R TTC611TCC F204S
S. aureus W41757 . . . . . C R TTC611TCC F204S
S. epidermidis 1026_SEPI . . . . . C R TTC611TCC F204S
S. haemolyticus 25-38 . . . . . C R TTC611TCC F204S
S. haemolyticus 25-60 . . . . . C R TTC611TCC F204S
S. haemolyticus 51-11 . . . . . C R TTC611TCC F204S
S. haemolyticus 51-13 . . . . . C R TTC611TCC F204S
S. haemolyticus 51-43 . . . . . C R TTC611TCC F204S
S. haemolyticus 51-41 . . . . . C R TTC611TCC F204S
S. haemolyticus 113101 . . . . . C R TTC611TCC F204S
S. haemolyticus 127925 . . . . . C R TTC611TCC F204S
S. warneri NGS-ED-1001 . . . . . C R TTC611TCC F204S
*Polymorphic sites are indicated with respect to the sh-fabI sequence of S. haemolyticus strain JCSC1435. **Phenotype as defined in references: (Ciusa et al., 2012; Grandgirard et al.,
2015). ***These wt S. haemolyticus strains do not carry the TnSha1 element, therefore the fabI sequence reported is the one of the core genome.
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must presumably have happened in S. haemolyticus since the
sh-fabI derives from the core genome of this species and both
elements are also present in this species. It is again not easy
to hypothesize any rationale for the almost exclusive presence
of TnSha1 in S. aureus, nor for the preferential presence of
TnSha2 in S. haemolyticus. The lack of primary target sequence
specificity and the peculiarity of targeting hairpin secondary
structures make the elements very versatile and would allow for
transposition to many locations within the chromosome and on
plasmids. While intact IS1272 itself is not present in S. aureus the
apparent selection for TnSha1 has very efficiently allowed spread
of the element in this species. In the case of TnSha2 the presence
of mobilization genes could indicate that this plasmid may be
horizontally transferable. Unfortunately, as in the case of the dfr
genes (Dale et al., 1995; Leelaporn et al., 1996), none of these
data provide a solid molecular basis to explain the difference in
distribution of the two elements among staphylococcal species.
The explanation may however come from a closer look at the
structure of the elements themselves. Indeed the very limited
range of the diversity in the elements, and the SNPs present in
them, indicates they have a recent origin. Another important
aspect of the dynamics of spread of this element is related to
the different triclosan-resistance conferring SNPs which have
accumulated in sh-fabI. The presence of triclosan susceptible
and resistant alleles in the studied population suggests the first
event was acquisition of a susceptible sh-fabI allele followed by
the selection of resistant alleles after the transfer event by a
fabI targeting agent, most probably triclosan (Ciusa et al., 2012;
Oggioni et al., 2012, 2013; Morrissey et al., 2014; Grandgirard
et al., 2015). This sequence of events in which the acquisition of
a resistance element is followed by the selection of more efficient
alleles is also the basis of the diversification of other resistance
elements as plasmids-encoded beta-lactamases (Bush, 2013).
Type II fatty acid metabolism, and in particular FabI, are
among the most highly investigated targets for development
of antimicrobial compounds (Banerjee et al., 1994; Park et al.,
2007; Escaich et al., 2011; Kaplan et al., 2012). This remains
true even though there is now debate on the essentiality of
bacterial fatty metabolism during invasive infection because, at
least for group B streptococci, it has been reported that it is
possible to forage host derived fatty acids (Brinster et al., 2009;
Balemans et al., 2010). In this respect it is therefore of great
interest to monitor the spread of genetic elements which could
produce reduced susceptibility to new antibiotics whose action
is based on targeting and inhibition of FabI. In this regard it
is worth noting that our experimental screening of a collection
of 1602 world-wide clinical S. aureus isolates detected sh-fabI
in 24/1602 of strains (1.5%; Ciusa et al., 2012), which matched
perfectly with the in silico screen of a database of microbial
genomes that detected sh-fabI carrying elements in 65/4127 S.
aureus strains (1.57%). This exact overlap in prevalence indicates
that genome databases of such size can now serve as suitable
datasets for epidemiological investigation, even though databases
generally lack detailed background information on strains. While
1.5% may not appear to be a high background resistance level
in a population, it could still be a worrying presence when
introducing a new FabI-targeting agent. Even worse is the
detection of sh-fabI elements in 14% of S. epidermidis isolates;
this appears to reach levels at which clinical use, including the
use of triclosan as disinfectant for decontamination, could be
jeopardized. It remains possible however that the lower sample
size, of <300 genomes screened, and the absence of clinical
information on these strains may limit the relevance of this
observation.
In order to correlate our data with two well-known examples
of IS-mobilizable metabolic genes, we have checked the relative
occurrence of the dfrA-thyE genes (Rouch et al., 1989), conferring
trimethoprim resistance, and ileS2 genes (Needham et al., 1994),
conferring mupirocin resistance, in the same 4800 staphylococcal
genomes. BLAST searches for dfrA-thyE yielded 279 hits in S.
aureus and 134 in S. epidermidis, while ileS2 yielded 207 hits
in S. aureus and 18 in S. epidermidis. This compares well with
the detection rate in our work of 65 TnSha1/2 elements in
S. aureus and 50 in S. epidermidis. These numbers indicate
that IS mediated transfer of metabolic resistance genes, in our
case sh-fabI genes and triclosan resistance, is a highly relevant
mechanism for the acquisition and spread of antibiotic resistance.
These data show that it is not only plasmids which serve as vectors
of IS mediated resistance gene transfers, but that the spread of
composite transposons can also be a highly efficient mechanism
for such a goal. A similar well-described mechanisms also exist
in staphylococci for the antibiotic resistance genes for example in
Tn4001, Tn4002, and Tn4003, (Lanza et al., 2015).
In conclusion our data show that IS mediated transposition
of metabolic genes represents a vast and growing antimicrobial
resistance phenomenon. In addition to the well-described
Tn4003 element, which mobilizes dfrA by way of three IS257
thereby conferring trimethoprim resistance (Rouch et al.,
1989), or the IS257 mediated mobilization of ileS2 conferring
mupirocin resistance (Needham et al., 1995), this arsenal
now includes TnSha1 and TnSha2; these elements utilize IS
transposition, IS-targeted integration and plasmid mobilization
to allow transfer of the fabI gene of S. haemolyticus to different
staphylococci and thereby contribute to triclosan resistance and,
potentially, to resistance for other FabI-targeting drugs. These
data show that IS mobilization of metabolic genes is a powerful
and highly flexible mechanism that can very rapidly provide
resistance phenotypes to vast numbers of strains and species.
In this era where thousands of genomes are readily available in
public databases the analysis of such IS mediated mobilization of
core genome metabolic genes may warrant a more detailed and
larger scale investigation.
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